Current resuscitation guidelines for cardiac arrest specify 360-J shocks with monophasic waveform external defibrillators and 150-to 200-J shocks with biphasic waveform defibrillators. Whether to increase shock strength with biphasic waveform defibrillators when the initial shock fails is not clear. Stiell and colleagues used automatic external defibrillators with recording capabilities to conduct a randomized trial of biphasic waveform shocks fixed at 150 J for initial and 2 subsequent shocks versus a 200 J initial shock followed by escalating shock strengths of 300 J and 360 J in out-of-hospital cardiac arrest victims. First shock conversion was similar with either energy, but escalating shock strengths improved conversion to a stable rhythm after a failed first shock with no evidence of additional myocardial damage. Although the trial was not powered to assess long-term outcome, the findings support increasing shock strength after initial failed defibrillation and will inform future guidelines. See p 1511.
COMPARISON OF CLINICAL AND ADMINISTRATIVE DATA SOURCES FOR HOSPITAL CORONARY ARTERY BYPASS GRAFT SURGERY REPORT CARDS, by Shahian et al.
Cardiac surgeons have consistently led the effort to collect, analyze, and apply outcome data for the benefit of patients. Cardiac surgery is also the paradigm for public performance reporting. Public performance report cards and consumer demand for reliable, transparent outcomes data must be based on the highest quality, validated information that is rigorously analyzed with appropriate statistical methodology. The gold standard is a prospectively maintained, clinical database containing core clinical variables. Using both standard logistic regression and hierarchical models, the results of hospitals can be compared. There has always been debate about the use of administrative databases, designed for financial data, used as the dataset for report cards. This study by Shahian et al compared hospital cardiac surgery profiling based upon clinical data with profiling derived from contemporaneous administrative data. An audited and validated clinical registry has been available for all cardiac procedures in Massachusetts since 2002. Results for fiscal year 2003 isolated coronary artery bypass grafting surgery based upon these data were compared with those derived from a contemporaneous state administrative database, the latter using the inclusion/exclusion criteria and risk model of the Agency for Healthcare Research and Quality. There was a 27.4% disparity in isolated coronary artery bypass surgery volume, a 0.83% difference in observed in-hospital mortality (2.05% versus 2.88%), and one hospital determined to be an outlier only with the approach based on administrative data. The discrepancies in volumes and risk adjusted mortality were most notable for highervolume programs. The authors concluded cardiac surgery report cards using administrative data are problematic compared with those derived from audited and validated clinical data. Optimal statistical methodology for risk-adjustment and provider profiling has been controversial, however, and no statistical technique, regardless of its sophistication, can compensate for flawed data. See p 1518.
AMPLIFIED EXPRESSION PROFILING OF PLATELET TRANSCRIPTOME REVEALS CHANGES IN ARGININE METABOLIC PATHWAYS IN PATIENTS WITH SICKLE CELL DISEASE, by Raghavachari et al.
Functional studies in platelets have shown an association of sickle cell disease with an enhanced thrombotic state. In the current issue of Circulation, Raghavachari and colleagues examine the platelet transcriptome from patients with sickle cell disease and identify about 100 differentially expressed genes, most notably, genes involved in arginine metabolism and redox homeostasis. Further biochemical analyses confirmed the relevance of these findings. As sickle cell disease is associated with reduced nitric oxide and arginine bioavailability, these findings suggest potential therapeutic and diagnostic targets for disease treatment and identification. In addition, this is one of the first studies utilizing the platelet transcriptome for disease characterization. See p 1551.
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Percutaneous Balloon Aortic Valvuloplasty Revisited: Time for a Renaissance? See p e334. 
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